Evidence map›Paper›PMID 37712060›Full record

ArticleFrontiers in cellular and infection microbiology2023

In host evolution of beta lactam resistance during active treatment for

Natasha Spottiswoode, Samantha Hao, Estella Sanchez-Guerrero, Angela M Detweiler, Honey Mekonen, Norma Neff, Henriette Macmillan, Brian S Schwartz, Joanne Engel, Joseph L DeRisi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Natasha SpottiswoodeDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Samantha HaoJohns Hopkins School of Medicine, Baltimore, Maryland, MD, United States.
Estella Sanchez-GuerreroChan Zuckerberg Biohub, San Francisco, CA, United States.
Angela M DetweilerChan Zuckerberg Biohub, San Francisco, CA, United States.
Honey MekonenChan Zuckerberg Biohub, San Francisco, CA, United States.
Norma NeffChan Zuckerberg Biohub, San Francisco, CA, United States.
Henriette MacmillanDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Brian S SchwartzDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Joanne EngelDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Joseph L DeRisiChan Zuckerberg Biohub, San Francisco, CA, United States.
Steven A MillerDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, United States.
Charles R LangelierDivision of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Chan Zuckerberg Initiative (United States) · USUniversity of California, San Francisco · US

Funding

BIOLOGY OF INFECTIOUS DISEASES TRAINING PROGRAMT32AI007641 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW G DORSEY · 2000 to 2026
$6.9M
Profiling the Lung Transcriptome for Precision Diagnosis of Respiratory Infections using Host/Pathogen Metagenomic SequencingK23HL138461 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANGELIER, CHARLES · 2018 to 2021
$718k
NHLBI NIH HHS K23 HL138461NIAID NIH HHS T32 AI007641
6 · The paper itself

Abstract

Multidrug-resistant (MDR)

Indexed as

BacteremiaSepsisbeta-Lactam ResistanceCarbapenemsHumansPseudomonas aeruginosaUnited StatesCarbapenemsantimicrobial resistancegram negativegram-negative bacteriagram negative (G -) bacteriahospital epidemiologywhole-genome sequencing

Identifiers

PMID37712060
PMCPMC10499174
OpenAlexW4386309147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.